Active Biotech AB (publ) (STO:ACTI)
Sweden · Delayed Price · Currency is SEK 0.0708
-0.0010 (-1.39%)
May 21, 2026, 12:58 PM CET
Active Biotech AB Market Cap
Active Biotech AB has a market cap or net worth of 189.27 million as of May 21, 2026. Its market cap has increased by 88.55% in one year.
Market Cap
189.27M
Enterprise Value
136.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since March 11, 1998, Active Biotech AB's market cap has decreased from 693.06M to 189.27M, a decrease of -72.69%. That is a compound annual growth rate of -4.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 189.27M | 56.09% |
| Dec 30, 2025 | 121.26M | 4.60% |
| Dec 30, 2024 | 115.93M | -29.80% |
| Dec 29, 2023 | 165.13M | -35.20% |
| Dec 30, 2022 | 254.82M | -7.51% |
| Dec 30, 2021 | 275.52M | 0.37% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 229.15M |
| Xbrane Biopharma AB | 228.72M |
| Initiator Pharma | 210.15M |
| Xintela AB | 199.81M |
| Diamyd Medical AB | 181.64M |
| Nanologica AB | 161.10M |
| AlzeCure Pharma AB | 160.88M |
| Elicera Therapeutics AB | 145.61M |